Skip to search formSkip to main contentSkip to account menu

vericiguat

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Heterocyclic Compounds, 2-RingPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Victoria Trial: Vericiguat Joins the Big League, or Does it?
The VICTORIA trial showed Vericiguat once daily (titrated up to 10 mg) significantly reduced its primary end-point, the composite… 
2020
2020
Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Reply
Guanylate Cyclase Stimulator in Heart Failure with Reduced Ejection Fraction) trial, which showed a trend towards decline in… 
2020
2020
VERICIGUAT IMPROVES AORTIC WAVE REFLECTION PARAMETERS AND AUGMENTATION INDEX IN A NEW PRECLINICAL MODEL OF HYPERTENSION
2018
2018
Vericiguat. Soluble guanylate cyclase (sGC) activator, Heart failure therapy
2017
2017
Abstract 17778: Combination of Soluble Guanylate Cyclase Stimulation and Mineralocorticoid Receptor Antagonism as New Treatment Option for Heart Failure With Preserved Ejection Fraction (hfpef…
Introduction: There is a substantial unmet medical need for new and efficacious treatment options for HFpEF. Combination of… 
2017
2017
John McMurray MD FESC.
For John McMurray, Professor of Cardiology at the University of Glasgow, UK, heart failure (HF) continues to be an amazing and… 
2015
2015
Neue Therapiekonzepte zur Herzinsuffizienz mit erhaltener Ejektionsfraktion
ZusammenfassungDas Management von Patienten mit Herzinsuffizienzsymptomen und erhaltener Ejektionsfraktion (HFpEF) bleibt eine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)